- Home
- BMRN vs KTOS Comparison
BMRN vs KTOS Comparison
Compare BMRN & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- KTOS
- Stock Information
- Founded
- BMRN 1996
- KTOS 1994
- Country
- BMRN United States
- KTOS United States
- Employees
- BMRN N/A
- KTOS N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- KTOS Military/Government/Technical
- Sector
- BMRN Health Care
- KTOS Industrials
- Exchange
- BMRN Nasdaq
- KTOS Nasdaq
- Market Cap
- BMRN 10.0B
- KTOS 10.0B
- IPO Year
- BMRN 1999
- KTOS 1999
- Fundamental
- Price
- BMRN $52.47
- KTOS $95.30
- Analyst Decision
- BMRN Buy
- KTOS Buy
- Analyst Count
- BMRN 18
- KTOS 14
- Target Price
- BMRN $93.71
- KTOS $70.43
- AVG Volume (30 Days)
- BMRN 2.2M
- KTOS 6.2M
- Earning Date
- BMRN 10-28-2025
- KTOS 11-06-2025
- Dividend Yield
- BMRN N/A
- KTOS N/A
- EPS Growth
- BMRN 154.69
- KTOS 31.73
- EPS
- BMRN 3.40
- KTOS 0.09
- Revenue
- BMRN $3,063,608,000.00
- KTOS $1,213,100,000.00
- Revenue This Year
- BMRN $13.35
- KTOS $17.66
- Revenue Next Year
- BMRN $9.18
- KTOS $18.10
- P/E Ratio
- BMRN $15.44
- KTOS $1,007.23
- Revenue Growth
- BMRN 18.36
- KTOS 7.76
- 52 Week Low
- BMRN $51.57
- KTOS $22.69
- 52 Week High
- BMRN $73.51
- KTOS $112.57
- Technical
- Relative Strength Index (RSI)
- BMRN 38.26
- KTOS 66.69
- Support Level
- BMRN $51.79
- KTOS $92.91
- Resistance Level
- BMRN $55.39
- KTOS $112.57
- Average True Range (ATR)
- BMRN 1.36
- KTOS 5.79
- MACD
- BMRN -0.11
- KTOS 0.58
- Stochastic Oscillator
- BMRN 19.28
- KTOS 54.01
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.